Samenvatting
Transforming growth factor beta (TGF-β) is a hormonally regulated growth inhibitor with autocrine and/or paracrine functions in human breast cancer. In vivo, enhanced immunohistochemical staining of extracellular TGF-β1 has been detected around stromal fibroblasts in response to the antiestrogen treatment. We have investigated the effects of tamoxifen on the production of TGF-β by primary human breast fibroblast cultures in serum-free medium. Highly variable levels of mainly latent TGF-β1 were detected in conditioned media from both tumor and normal tissue derived fibroblasts. Hydroxy-tamoxifen was shown to increase latent TGF-β1 secretion in three of the eight tumor tissue-derived fibroblast cultures. Such effect of hydroxy-tamoxifen was not observed in fibroblast cultures established from normal adjacent breast tissue.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 1-6 |
Aantal pagina's | 6 |
Tijdschrift | Molecular and Cellular Endocrinology |
Volume | 111 |
Nummer van het tijdschrift | 1 |
DOI's | |
Status | Gepubliceerd - 28 apr. 1995 |
Extern gepubliceerd | Ja |